Fundraising FoxAlpfa Medical
Palo Alto, US · Founded 2021
Find your way into Alpfa Medical
Sign up to see every warm intro you have to Alpfa Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alpfa Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AlpfaMed develops a Pulsed Field Ablation (PFA) technology that uses targeted, heat-free electrical energy to remodel prostate tissue and treat Benign Prostatic Hyperplasia (BPH). The approach is designed as a tissue-selective, incision-free alternative to conventional surgical and heat-based BPH treatments for men.
Founders & leadership
Board
DB
David BonitaBoard director
AE
Andrew ElBardissiBoard director
MH
Michael HurleyBoard director
MK
Michael KramerBoard director
RV
Raju ViswanathanBoard director
Reported raises · per SEC filings
Form D private placements$80.3M disclosed across 1 round · 2026
▶$80.3MraisedSep 2026 · 71 investors · Other Health CareRule 506(b)
▶$80.3MraisedSep 2026 · 71 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Allan ZingelerExecutive Officer, Director
- David BonitaDirector
- Andrew ElBardissiDirector
- Michael HurleyDirector
- Michael KramerDirector
- Raju ViswanathanDirector
- Michael WileyExecutive Officer, Director
- Rupa PatelExecutive Officer
- Offering amount
- $100.3M
- Amount sold
- $80.3M
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Alpfa Medical do?
- AlpfaMed develops a Pulsed Field Ablation (PFA) technology that uses targeted, heat-free electrical energy to remodel prostate tissue and treat Benign Prostatic Hyperplasia (BPH). The approach is designed as a tissue-selective, incision-free alternative to conventional surgical and heat-based BPH treatments for men.
- How much funding has Alpfa Medical raised?
- Alpfa Medical has disclosed $80.3M raised across 1 round.
- Where is Alpfa Medical headquartered?
- Alpfa Medical is headquartered in Palo Alto, US.